Bavarian Drops RSV Program After Phase III Flop

Shifts Focus To Chikungunya

neon red exit sign against sunset sky
Bavarian Is Leaving The RSV Space After An Unexpected Disappointment • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D